Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Hyacinths Pharma Private Limited, was an unlisted private company incorporated on 23 July, 2010. It is classified as a private limited company and is located in , Telangana. It's authorized share capital was INR 35.00 cr and the total paid-up capital was INR 32.50 cr.
The current status of Hyacinths Pharma Private Limited is - Amalgamated.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Nityananda Reddy Kambam | 01284195 | 12 years |
Director | Venkateswararao Kondreddy | 02907769 | 8 years |
Director | Karri Satyanarayana Reddy | 08434241 | 6 years |
Kmp | Venkata Sudheer Babu Gonugunta | <HIDDEN> | 6 years |
Kmp | Venkata Subrahamanya Sarma Musunuri | <HIDDEN> | 6 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
AUROBINDO PHARMA LTD |
Active
|
58.1 Cr | 1 | Telangana |
TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 1 | Telangana |
RAIDURGAM DEVELOPERS LIMITED |
Active
|
10.0 Cr | 2 | Telangana |
APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 1 | Telangana |
SENOR ORGANICS PVT LTD |
Amalgamated
|
1.5 Cr | 1 | Telangana |
AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 1 | Telangana |
SILICON LIFE SCIENCES PRIVATE LIMITED |
Amalgamated
|
110.0 Cr | 2 | Telangana |
AUROBINDO ANTIBIOTICS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Andhra Pradesh |
QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 1 | Telangana |
APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 1 | Telangana |
APL HEALTHCARE LIMITED |
Active
|
216.0 Cr | 1 | Telangana |
PATTANCHERU ENVIRO-TECH LIMITED |
Active
|
2.6 Cr | 1 | Telangana |
LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
PROWINHEALTH TECHNOLOGIES PRIVATE LIMITED |
Active
|
20.1 L | 1 | Telangana |
NARMADA INFRASTRUCTURE CONSTRUCTION ENTE RPRISE LIMITED |
Amalgamated
|
47.4 Cr | 1 | Tamil Nadu |
Read more
The incorporation date of HYACINTHS PHARMA PRIVATE LIMITED is 23 July, 2010
The authorized share capital of HYACINTHS PHARMA PRIVATE LIMITED is INR ₹ 35.0 Cr.
The paid-up capital of HYACINTHS PHARMA PRIVATE LIMITED is INR ₹ 32.5 Cr.
The registered address of HYACINTHS PHARMA PRIVATE LIMITED is PLOT NO.2, MAITRIVIHAR AMEERPET HYDERABAD Hyderabad Telangana - 500038
The CIN number of HYACINTHS PHARMA PRIVATE LIMITED is U24232TG2010PTC069638.